Linda R. Tulner

827 total citations
24 papers, 592 citations indexed

About

Linda R. Tulner is a scholar working on Geriatrics and Gerontology, Psychiatry and Mental health and Epidemiology. According to data from OpenAlex, Linda R. Tulner has authored 24 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Geriatrics and Gerontology, 7 papers in Psychiatry and Mental health and 5 papers in Epidemiology. Recurrent topics in Linda R. Tulner's work include Pharmaceutical Practices and Patient Outcomes (7 papers), Alzheimer's disease research and treatments (4 papers) and Dementia and Cognitive Impairment Research (3 papers). Linda R. Tulner is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (7 papers), Alzheimer's disease research and treatments (4 papers) and Dementia and Cognitive Impairment Research (3 papers). Linda R. Tulner collaborates with scholars based in Netherlands, New Zealand and United States. Linda R. Tulner's co-authors include Jos H. Beijnen, Jos P.C.M. van Campen, Suzanne V. Frankfort, Cornelis H.W. Koks, Desiderius P.M. Brandjes, Ingeborg M.J.A. Kuper, Claudine J. C. Lamoth, Maartje H. de Groot, Marcel M. Verbeek and R.W.M.M. Jansen and has published in prestigious journals such as Age and Ageing, Patient Education and Counseling and International Journal of Geriatric Psychiatry.

In The Last Decade

Linda R. Tulner

22 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda R. Tulner Netherlands 14 191 133 103 94 84 24 592
Barry Cusack United States 7 154 0.8× 123 0.9× 85 0.8× 82 0.9× 38 0.5× 12 545
Paul A.F. Jansen Netherlands 17 171 0.9× 85 0.6× 135 1.3× 110 1.2× 53 0.6× 25 589
Fabienne Bazin France 13 174 0.9× 93 0.7× 234 2.3× 54 0.6× 147 1.8× 21 787
Victor Crentsil United States 9 196 1.0× 92 0.7× 51 0.5× 81 0.9× 43 0.5× 16 421
Ivy O. Poon United States 10 177 0.9× 267 2.0× 74 0.7× 67 0.7× 20 0.2× 29 606
S. H. D. Jackson United Kingdom 11 121 0.6× 94 0.7× 86 0.8× 66 0.7× 38 0.5× 32 667
Philippe Cestac France 14 296 1.5× 273 2.1× 184 1.8× 131 1.4× 25 0.3× 60 867
Carrie S. Swift United States 9 197 1.0× 123 0.9× 63 0.6× 72 0.8× 35 0.4× 13 1.5k
Cecilia Della Vedova Italy 9 350 1.8× 91 0.7× 44 0.4× 134 1.4× 29 0.3× 10 616
A Nørgaard Denmark 18 142 0.7× 218 1.6× 194 1.9× 58 0.6× 33 0.4× 33 815

Countries citing papers authored by Linda R. Tulner

Since Specialization
Citations

This map shows the geographic impact of Linda R. Tulner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda R. Tulner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda R. Tulner more than expected).

Fields of papers citing papers by Linda R. Tulner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda R. Tulner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda R. Tulner. The network helps show where Linda R. Tulner may publish in the future.

Co-authorship network of co-authors of Linda R. Tulner

This figure shows the co-authorship network connecting the top 25 collaborators of Linda R. Tulner. A scholar is included among the top collaborators of Linda R. Tulner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda R. Tulner. Linda R. Tulner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pel‐Littel, Ruth, Bianca M. Buurman, Marjolein van de Pol, et al.. (2023). Effects of a shared decision making intervention for older adults with multiple chronic conditions: the DICO study. BMC Medical Informatics and Decision Making. 23(1). 42–42. 12 indexed citations
2.
Hooft, Lotty, Linda R. Tulner, J.H.M. Tulen, et al.. (2014). Acetaminophen for self-reported sleep problems in an elderly population (ASLEEP): study protocol of a randomized placebo-controlled double-blind trial. Trials. 15(1). 10–10. 4 indexed citations
3.
Groot, Maartje H. de, et al.. (2013). The Effects of Fall-Risk-Increasing Drugs on Postural Control: A Literature Review. Drugs & Aging. 30(11). 901–920. 76 indexed citations
4.
Willems, Hanna C., Marijn Vis, Barbara C. Van Munster, et al.. (2012). Why do geriatric outpatients have so many moderate and severe vertebral fractures? Exploring prevalence and risk factors. Age and Ageing. 41(2). 200–206. 19 indexed citations
5.
Tulner, Linda R., Ingeborg M.J.A. Kuper, Jos P.C.M. van Campen, et al.. (2010). Contraindications for Anticoagulation in Older Patients with Atrial Fibrillation: A Narrative Review. Current Drug Safety. 5(3). 223–233. 6 indexed citations
6.
Tulner, Linda R., Jos P.C.M. van Campen, Suzanne V. Frankfort, et al.. (2010). Changes in Under-Treatment after Comprehensive Geriatric Assessment. Drugs & Aging. 27(10). 831–843. 20 indexed citations
7.
Tulner, Linda R., Ingeborg M.J.A. Kuper, Jos P.C.M. van Campen, et al.. (2009). Treatment of hypertension in an elderly outpatient population in the Netherlands. ˜The œAmerican journal of geriatric pharmacotherapy. 7(4). 204–209. 4 indexed citations
8.
Tulner, Linda R., Jos P.C.M. van Campen, Ingeborg M.J.A. Kuper, et al.. (2009). Reasons for Undertreatment with Oral Anticoagulants in Frail Geriatric Outpatients with Atrial Fibrillation. Drugs & Aging. 27(1). 39–50. 82 indexed citations
9.
Tulner, Linda R., Ingeborg M.J.A. Kuper, Suzanne V. Frankfort, et al.. (2009). Discrepancies in reported drug use in geriatric outpatients: Relevance to adverse events and drug-drug interactions. ˜The œAmerican journal of geriatric pharmacotherapy. 7(2). 93–104. 56 indexed citations
10.
Tulner, Linda R., et al.. (2008). Drug-Drug Interactions in a Geriatric Outpatient Cohort. Drugs & Aging. 25(4). 343–355. 107 indexed citations
11.
Frankfort, Suzanne V., et al.. (2008). Amyloid Beta Protein and Tau in Cerebrospinal Fluid and Plasma as Biomarkers for Dementia: A Review of Recent Literature. Current Clinical Pharmacology. 3(2). 123–131. 57 indexed citations
12.
13.
Frankfort, Suzanne V., Mariët Ouwehand, M. J. van Maanen, et al.. (2006). A simple and sensitive assay for the quantitative analysis of rivastigmine and its metabolite NAP 226‐90 in human EDTA plasma using coupled liquid chromatography and tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 20(22). 3330–3336. 26 indexed citations
14.
Frankfort, Suzanne V., Bregje A. Appels, A de Boer, et al.. (2006). Identification of responders and reactive domains to rivastigmine in Alzheimer's disease. Pharmacoepidemiology and Drug Safety. 16(5). 545–551. 17 indexed citations
15.
Frankfort, Suzanne V., Linda R. Tulner, Jos P.C.M. van Campen, Cornelis H.W. Koks, & Jos H. Beijnen. (2006). Evaluation of Pharmacotherapy in Geriatric Patients after Performing Complete Geriatric Assessment at a??Diagnostic Day Clinic. Clinical Drug Investigation. 26(3). 169–174. 17 indexed citations
16.
Frankfort, Suzanne V., Bregje A. Appels, Linda R. Tulner, et al.. (2006). Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric setting. International Journal of Clinical Practice. 60(6). 646–654. 15 indexed citations
17.
Frankfort, Suzanne V., Linda R. Tulner, Jos P.C.M. van Campen, Cornelis H.W. Koks, & Jos H. Beijnen. (2006). The effect of admission to a geriatric ward on medication use: 2002 versus 1985. Pharmacoepidemiology and Drug Safety. 15(8). 602–606.
18.
Frankfort, Suzanne V., et al.. (2006). ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients.. Molecular Neurodegeneration. 1(1). 13–13. 13 indexed citations
19.
Frankfort, Suzanne V., Bregje A. Appels, Anthonius de Boer, et al.. (2005). Discontinuation of rivastigmine in routine clinical practice. International Journal of Geriatric Psychiatry. 20(12). 1167–1171. 14 indexed citations
20.
Tulner, Linda R., et al.. (1997). Immunosenescence Revisited. Drugs & Aging. 11(1). 1–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barry Cusack Breakdown of academic impact, for papers by Paul A.F. Jansen Breakdown of academic impact, for papers by Fabienne Bazin Breakdown of academic impact, for papers by Victor Crentsil Breakdown of academic impact, for papers by Ivy O. Poon Breakdown of academic impact, for papers by S. H. D. Jackson Breakdown of academic impact, for papers by Philippe Cestac Breakdown of academic impact, for papers by Carrie S. Swift Breakdown of academic impact, for papers by Cecilia Della Vedova Breakdown of academic impact, for papers by A Nørgaard
Rankless by CCL
2026